biote Corp. (BTMD)
NASDAQ: BTMD
· Real-Time Price · USD
3.31
-0.23 (-6.50%)
At close: Apr 30, 2025, 2:33 PM
biote Revenue Breakdown
| Period Ending | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Dietary Supplements Revenue | 10.32M | 7.39M | 9.13M | 8.47M | 12.15M | 8.33M | 24.46M | 8.07M | 7.95M |
| Dietary Supplements Revenue Growth | +39.63% | -19.11% | +7.79% | -30.25% | +45.86% | -65.95% | +203.29% | +1.47% | n/a |
| Other Service Revenue Revenue | 702K | 221K | 206K | 171K | 178K | 142K | 122.34M | 41.57M | 40.79M |
| Other Service Revenue Revenue Growth | +217.65% | +7.28% | +20.47% | -3.93% | +25.35% | -99.88% | +194.28% | +1.92% | n/a |
| Product Revenue Revenue | 49.81M | 46.03M | 44.94M | 44.83M | 48.65M | 44.16M | 1.25M | 396K | 570K |
| Product Revenue Revenue Growth | +8.19% | +2.45% | +0.23% | -7.85% | +10.18% | +3421.13% | +216.67% | -30.53% | n/a |
| Service Revenue Revenue | 1.58M | 769K | 768K | 726K | 605K | 688K | 617K | 186K | 356K |
| Service Revenue Revenue Growth | +105.20% | +0.13% | +5.79% | +20.00% | -12.06% | +11.51% | +231.72% | -47.75% | n/a |
| Training Service Revenue Revenue | 573K | 274K | 983K | 321K | 202K | -336K | n/a | n/a | n/a |
| Training Service Revenue Revenue Growth | +109.12% | -72.13% | +206.23% | +58.91% | -160.12% | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|
| All Other Country Revenue | 735K | 434K |
| All Other Country Revenue Growth | +69.35% | n/a |
| United States Revenue | 181.84M | 164.52M |
| United States Revenue Growth | +10.52% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 24.03M | 27.65M | 22.26M | 20.12M | 23.79M | 25.76M | 23.09M | 21.57M | 20.61M | 113.06M | 14.89M | 17.64M | 13.73M | 12.39M | 10.79M | 9.5M |
| Selling, General, and Administrative Revenue Growth | -13.10% | +24.21% | +10.64% | -15.43% | -7.64% | +11.59% | +7.01% | +4.67% | -81.77% | +659.47% | -15.59% | +28.47% | +10.83% | +14.80% | +13.58% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |